Insider · CIK 0001120477

PATEL DINESH V PH D

Reports to the SEC for 2 companies · NEWARK, CA

sec.gov

Transactions

Companies

Filings

CIK

0001120477

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-10	PTGXProtagonist Therapeutics, IncM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+7,278 sh	$21.58	+$157K	530,246
2026-09-10	PTGXProtagonist Therapeutics, IncS Sale	Director, President and CEO	SSale	−7,278 sh	$144.10	−$1.05M	522,968
2026-09-10	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−7,278 sh	—	—	0
2026-09-09	PTGXProtagonist Therapeutics, IncM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+63.5K sh	$21.58	+$1.37M	586,516
2026-09-09	PTGXProtagonist Therapeutics, IncS Sale	Director, President and CEO	SSale	−63.5K sh	$146.18	−$9.29M	522,968
2026-09-09	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−63.5K sh	—	—	7,278
2026-09-08	PTGXProtagonist Therapeutics, IncM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+54.2K sh	$21.58	+$1.17M	577,142
2026-09-08	PTGXProtagonist Therapeutics, IncS Sale	Director, President and CEO	SSale	−54.2K sh	$145.87	−$7.9M	522,968
2026-09-08	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−54.2K sh	—	—	70,826
2026-09-03	PTGXProtagonist Therapeutics, IncG Gift	Director, President and CEO	GGift	−510 sh	—	—	522,968
2026-08-11	PTGXProtagonist Therapeutics, IncM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+34.2K sh	$21.58	+$739K	557,717
2026-08-11	PTGXProtagonist Therapeutics, IncS Sale	Director, President and CEO	SSale	−34.2K sh	$148.52	−$5.09M	523,478
2026-08-11	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−34.2K sh	—	—	125,000
2026-08-10	PTGXProtagonist Therapeutics, IncM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+65.8K sh	$21.58	+$1.42M	589,239
2026-08-10	PTGXProtagonist Therapeutics, IncS Sale	Director, President and CEO	SSale	−65.8K sh	$149.11	−$9.81M	523,478
2026-08-10	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−65.8K sh	—	—	159,239
2026-05-12	PTGXProtagonist Therapeutics, IncM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+75K sh	$21.58	+$1.62M	598,478
2026-05-12	PTGXProtagonist Therapeutics, IncS Sale	Director, President and CEO	SSale	−75K sh	$100.12	−$7.51M	523,478
2026-05-12	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−75K sh	—	—	225,000
2026-05-12	PTGXProtagonist Therapeutics, IncM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+75K sh	$21.58	+$1.62M	598,478
2026-05-12	PTGXProtagonist Therapeutics, IncS Sale	Director, President and CEO	SSale	−75K sh	$100.12	−$7.51M	523,478
2026-05-12	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−75K sh	—	—	225,000
2026-04-23	PTGXProtagonist Therapeutics, IncG Gift	Director, President and CEO	GGift	−1,460 sh	—	—	523,478
2026-03-25	PTGXProtagonist Therapeutics, IncM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+54.6K sh	$8.58	+$469K	579,579
2026-03-25	PTGXProtagonist Therapeutics, IncS Sale	Director, President and CEO	SSale	−54.6K sh	$101.00	−$5.52M	524,938
2026-03-25	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−54.6K sh	—	—	0
2026-03-24	PTGXProtagonist Therapeutics, IncM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+59 sh	$8.58	+$506.22	524,997
2026-03-24	PTGXProtagonist Therapeutics, IncS Sale	Director, President and CEO	SSale	−59 sh	$101.00	−$5,959	524,938
2026-03-24	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−59 sh	—	—	54,641
2026-03-23	PTGXProtagonist Therapeutics, IncG Gift	Director, President and CEO	GGift	−50K sh	—	—	524,938
2026-01-27	PTGXProtagonist Therapeutics, IncM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+4,068 sh	$21.58	+$87.8K	578,573
2026-01-27	PTGXProtagonist Therapeutics, IncS Sale	Director, President and CEO	SSale	−4,068 sh	$83.19	−$338K	574,505
2026-01-27	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−4,068 sh	—	—	300,000
2026-01-26	PTGXProtagonist Therapeutics, IncM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+10.7K sh	$4.21	+$45K	585,190
2026-01-26	PTGXProtagonist Therapeutics, IncS Sale	Director, President and CEO	SSale	−10.7K sh	$84.00	−$898K	574,505
2026-01-26	PTGXProtagonist Therapeutics, IncM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+14.2K sh	$21.58	+$307K	588,710
2026-01-26	PTGXProtagonist Therapeutics, IncS Sale	Director, President and CEO	SSale	−14.2K sh	$84.05	−$1.19M	574,505
2026-01-26	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−10.7K sh	—	—	0
2026-01-26	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−14.2K sh	—	—	304,068
2026-01-23	PTGXProtagonist Therapeutics, IncG Gift	Director, President and CEO	GGift	−6,000 sh	—	—	574,505
2026-01-23	PTGXProtagonist Therapeutics, IncM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+19.3K sh	$4.21	+$81.3K	593,820
2026-01-23	PTGXProtagonist Therapeutics, IncS Sale	Director, President and CEO	SSale	−19.3K sh	$84.59	−$1.63M	574,505
2026-01-23	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−19.3K sh	—	—	10,685
2026-01-20	PTGXProtagonist Therapeutics, IncS Sale	Director, President and CEO	SSale	−34.4K sh	$82.48	−$2.84M	580,505
2026-01-02	PTGXProtagonist Therapeutics, IncA Award	Director, President and CEO	AAward	+95.4K sh	—	—	614,943
2026-01-02	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)A Award	Director, President and CEO	AAward	+120K sh	—	—	120,200
2025-11-21	PTGXProtagonist Therapeutics, IncG Gift	Director, President and CEO	GGift	−440 sh	—	—	519,543
2025-09-16	PTGXProtagonist Therapeutics, IncG Gift	Director, President and CEO	GGift	−620 sh	—	—	519,983
2025-07-25	PTGXProtagonist Therapeutics, IncS Sale	Director, President and CEO	SSale	−10.4K sh	$54.78	−$571K	520,603
2025-07-23	PTGXProtagonist Therapeutics, IncS Sale	Director, President and CEO	SSale	−17.5K sh	$54.79	−$960K	531,018

Recent filings

Accepted (ET)
Sep 104
PATEL DINESH V PH D0001104659-26-106831
SEC(opens sec.gov)
Sep 84
PATEL DINESH V PH D0001104659-26-105955
SEC(opens sec.gov)
Aug 124
PATEL DINESH V PH D0001104659-26-095111
SEC(opens sec.gov)
May 144/A
PATEL DINESH V PH D0001104659-26-061476
SEC(opens sec.gov)
May 124
PATEL DINESH V PH D0001104659-26-059591
SEC(opens sec.gov)

Companies

Address

C/O PROTAGONIST THERAPEUTICS, INC. 7707 GATEWAY BLVD., SUITE 140

NEWARK, CA, 94560-1160